Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of High Risk Acute Leukemia With CD40 Ligand and IL-2 Gene Modified Autologous Skin Fibroblasts and Tumor Cells

NCT00058799 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00058799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00058799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of High Risk Acute Leukemia With CD40 Ligand and IL-2 Gene Modified Autologous Skin Fibroblasts and Tumor Cells
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 30, 1999
Completion date
June 30, 2010
Enrollment
11 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia